Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WBP1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DNAJC9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GMPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMED4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VTA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CUTA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD54 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL10A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS15A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARID5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTHFD2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LARP4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAT5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on